| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
|
Ophthalmology
|
2011
|
4.96
|
|
2
|
Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
|
Ophthalmology
|
2004
|
2.49
|
|
3
|
Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study.
|
Retina
|
2008
|
2.06
|
|
4
|
Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.
|
Am J Ophthalmol
|
2007
|
1.95
|
|
5
|
Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.
|
Ophthalmology
|
2008
|
1.88
|
|
6
|
Epiretinal membrane formation with internal limiting membrane wrinkling after Nd:YAG laser membranotomy in valsalva retinopathy.
|
Am J Ophthalmol
|
2003
|
1.70
|
|
7
|
Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization.
|
Am J Ophthalmol
|
2006
|
1.69
|
|
8
|
Indocyanine green-assisted internal limiting membrane removal in epiretinal membrane surgery: a clinical and histologic study.
|
Am J Ophthalmol
|
2004
|
1.69
|
|
9
|
Macular hole surgery with or without indocyanine green stained internal limiting membrane peeling.
|
Clin Experiment Ophthalmol
|
2003
|
1.64
|
|
10
|
Pars plana vitrectomy in the management of retained intravitreal lens fragments after cataract surgery.
|
Clin Experiment Ophthalmol
|
2002
|
1.54
|
|
11
|
Internal limiting membrane staining with various concentrations of indocyanine green dye under air in macular surgeries.
|
Am J Ophthalmol
|
2003
|
1.51
|
|
12
|
Tyrosinase gene (TYR) mutations in Chinese patients with oculocutaneous albinism type 1.
|
Clin Experiment Ophthalmol
|
2010
|
1.43
|
|
13
|
Intravitreal bevacizumab in inflammatory ocular neovascularization.
|
Am J Ophthalmol
|
2008
|
1.36
|
|
14
|
Efficacy of 1.25 MG versus 2.5 MG intravitreal bevacizumab for diabetic macular edema: six-month results of a randomized controlled trial.
|
Retina
|
2009
|
1.27
|
|
15
|
Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
|
Ophthalmology
|
2007
|
1.26
|
|
16
|
Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.
|
Ophthalmology
|
2007
|
1.26
|
|
17
|
Presence of crystalline lens as a protective factor for the late development of open angle glaucoma after vitrectomy.
|
Retina
|
2009
|
1.25
|
|
18
|
Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series.
|
Ophthalmology
|
2003
|
1.13
|
|
19
|
Choroidal neovascularization in pathological myopia.
|
Prog Retin Eye Res
|
2012
|
1.10
|
|
20
|
Compound heterozygosity of two novel truncation mutations in RP1 causing autosomal recessive retinitis pigmentosa.
|
Invest Ophthalmol Vis Sci
|
2009
|
1.03
|
|
21
|
Photodynamic therapy in macular diseases of asian populations: when East meets West.
|
Jpn J Ophthalmol
|
2006
|
1.01
|
|
22
|
Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one-year results of a prospective series.
|
Retina
|
2008
|
1.01
|
|
23
|
Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema.
|
Clin Interv Aging
|
2013
|
0.99
|
|
24
|
Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy.
|
Ophthalmic Res
|
2011
|
0.99
|
|
25
|
Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia.
|
Retina
|
2008
|
0.97
|
|
26
|
Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization.
|
Can J Ophthalmol
|
2012
|
0.96
|
|
27
|
Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin.
|
Am J Ophthalmol
|
2003
|
0.96
|
|
28
|
Associations of the C2-CFB-RDBP-SKIV2L locus with age-related macular degeneration and polypoidal choroidal vasculopathy.
|
Ophthalmology
|
2012
|
0.93
|
|
29
|
Long-Term Follow-Up of Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization due to Choroidal Osteoma.
|
Case Rep Ophthalmol
|
2012
|
0.93
|
|
30
|
Differentiation of exudative age-related macular degeneration and polypoidal choroidal vasculopathy in the ARMS2/HTRA1 locus.
|
Invest Ophthalmol Vis Sci
|
2012
|
0.93
|
|
31
|
Results of high-density silicone oil as a tamponade agent in macular hole retinal detachment in patients with high myopia.
|
Br J Ophthalmol
|
2007
|
0.92
|
|
32
|
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.
|
Br J Ophthalmol
|
2006
|
0.90
|
|
33
|
A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema.
|
Br J Ophthalmol
|
2006
|
0.90
|
|
34
|
Endophotocoagulation to retinal pigment epithelium as an adjuvant therapy in the management of retinal detachment caused by a highly myopic macular hole.
|
Ophthalmic Surg Lasers
|
2002
|
0.90
|
|
35
|
Improvement in multifocal electroretinography after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy: a randomized placebo-controlled trial.
|
Retina
|
2011
|
0.90
|
|
36
|
Association of C2 and CFB polymorphisms with anterior uveitis.
|
Invest Ophthalmol Vis Sci
|
2012
|
0.88
|
|
37
|
Differential pattern of RP1 mutations in retinitis pigmentosa.
|
Mol Vis
|
2010
|
0.87
|
|
38
|
Central serous chorioretinopathy after solar eclipse viewing.
|
J Ophthalmic Vis Res
|
2010
|
0.87
|
|
39
|
The roles of genetic factors in uveitis and their clinical significance.
|
Retina
|
2014
|
0.86
|
|
40
|
Association of NR2E3 but not NRL mutations with retinitis pigmentosa in the Chinese population.
|
Invest Ophthalmol Vis Sci
|
2009
|
0.85
|
|
41
|
Novel and homozygous BEST1 mutations in Chinese patients with Best vitelliform macular dystrophy.
|
Retina
|
2010
|
0.85
|
|
42
|
Extensive submacular haemorrhage in polypoidal choroidal vasculopathy managed by sequential gas displacement and photodynamic therapy: a pilot study of one-year follow up.
|
Clin Experiment Ophthalmol
|
2005
|
0.83
|
|
43
|
CFH 184G as a genetic risk marker for anterior uveitis in Chinese females.
|
Mol Vis
|
2011
|
0.83
|
|
44
|
Retinal pigment epithelial tear following intravitreal ranibizumab injections for neovascular age-related macular degeneration.
|
Graefes Arch Clin Exp Ophthalmol
|
2007
|
0.83
|
|
45
|
Review of Clinical Features, Microbiological Spectrum, and Treatment Outcomes of Endogenous Endophthalmitis over an 8-Year Period.
|
J Ophthalmol
|
2012
|
0.82
|
|
46
|
Association of genetic variants on 8p21 and 4q12 with age-related macular degeneration in Asian populations.
|
Invest Ophthalmol Vis Sci
|
2012
|
0.82
|
|
47
|
Association of CFH and SERPING1 polymorphisms with anterior uveitis.
|
Br J Ophthalmol
|
2013
|
0.82
|
|
48
|
Pediatric ocular surface infections: a 5-year review of demographics, clinical features, risk factors, microbiological results, and treatment.
|
Cornea
|
2011
|
0.82
|
|
49
|
Photodynamic therapy with verteporfin for vasoproliferative tumour of the retina.
|
Acta Ophthalmol
|
2010
|
0.81
|
|
50
|
Photodynamic therapy with verteporfin in laser-induced choroidal neovascularization.
|
Am J Ophthalmol
|
2003
|
0.81
|
|
51
|
Intravitreal dexamethasone for diabetic macular edema: a pilot study.
|
Ophthalmic Surg Lasers Imaging
|
2010
|
0.81
|
|
52
|
Complement factor H and interleukin gene polymorphisms in patients with non-infectious intermediate and posterior uveitis.
|
Mol Vis
|
2012
|
0.81
|
|
53
|
Clinical features of retinal diseases masquerading as retrobulbar optic neuritis.
|
Chin Med J (Engl)
|
2013
|
0.81
|
|
54
|
Correlation between functional and anatomical assessments by multifocal electroretinography and optical coherence tomography in central serous chorioretinopathy.
|
Doc Ophthalmol
|
2010
|
0.80
|
|
55
|
Clinical characteristics of intermediate uveitis in Chinese patients.
|
Ocul Immunol Inflamm
|
2013
|
0.80
|
|
56
|
Multifocal electroretinography in dengue fever-associated maculopathy.
|
Br J Ophthalmol
|
2007
|
0.80
|
|
57
|
Panuveitis as an initial presentation of extranodal NK/T-cell lymphoma.
|
Leuk Lymphoma
|
2009
|
0.80
|
|
58
|
Changes in first- and second-order multifocal electroretinography in idiopathic macular hole and their correlations with macular hole diameter and visual acuity.
|
Graefes Arch Clin Exp Ophthalmol
|
2009
|
0.79
|
|
59
|
Manganese superoxide dismutase and chemokine genes polymorphisms in chinese patients with anterior uveitis.
|
Invest Ophthalmol Vis Sci
|
2009
|
0.79
|
|
60
|
Black diaphragm aniridia intraocular lens for aniridia and albinism.
|
Graefes Arch Clin Exp Ophthalmol
|
2004
|
0.79
|
|
61
|
Understanding indocyanine green angiography in polypoidal choroidal vasculopathy: the group experience with digital fundus photography and confocal scanning laser ophthalmoscopy.
|
Retina
|
2014
|
0.78
|
|
62
|
Effect of application duration of 2% lidocaine jelly on aqueous lidocaine concentration for topical anesthesia in cataract surgery.
|
Graefes Arch Clin Exp Ophthalmol
|
2006
|
0.78
|
|
63
|
Factors associated with variability in response of diabetic macular oedema after intravitreal triamcinolone.
|
Clin Experiment Ophthalmol
|
2009
|
0.78
|
|
64
|
Prioritization of cataract surgery: visual analogue scale versus scoring system.
|
ANZ J Surg
|
2005
|
0.78
|
|
65
|
Laser photocoagulation of indocyanine green aniographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy.
|
Am J Ophthalmol
|
2004
|
0.78
|
|
66
|
Late appearance of an intracameral ophthalmic ointment globule after uneventful phacoemulsification.
|
Jpn J Ophthalmol
|
2009
|
0.77
|
|
67
|
Correlation of clinical and optical coherence tomography findings in postoperative macular hole closure status.
|
Ophthalmic Surg Lasers Imaging
|
2003
|
0.77
|
|
68
|
Anti-vascular endothelial growth factor therapy for myopic choroidal neovascularization: do we need more evidence?
|
Retina
|
2012
|
0.76
|
|
69
|
Bilateral elevated macular lesions.
|
J Ophthalmic Vis Res
|
2011
|
0.75
|
|
70
|
ILM peeling in macular hole surgery.
|
Ophthalmology
|
2002
|
0.75
|
|
71
|
Acrylic intraocular lens placement in conjunction with pars plana vitrectomy.
|
Am J Ophthalmol
|
2002
|
0.75
|
|
72
|
Iatrogenic punctate chorioretinopathy after internal limiting membrane peeling.
|
Am J Ophthalmol
|
2003
|
0.75
|
|
73
|
Results of trabeculectomy with adjunctive intraoperative mitomycin C in Chinese patients with glaucoma.
|
Ophthalmic Surg Lasers Imaging
|
2006
|
0.75
|
|
74
|
Letter to the Editor Regarding "The Endophthalmitis Kit".
|
Asia Pac J Ophthalmol (Phila)
|
2015
|
0.75
|
|
75
|
Managing Uveitis during the COVID-19 Pandemic.
|
Ophthalmology
|
2020
|
0.75
|
|
76
|
Safety and efficacy of micro-incisional cataract surgery with bimanual phacoemulsification for white mature cataract.
|
Ophthalmologica
|
2007
|
0.75
|
|
77
|
Fundus Autofluorescence Imaging in the Assessment of Acute Zonal Occult Outer Retinopathy.
|
Ophthalmologica
|
2017
|
0.75
|
|
78
|
Genetics of Bietti Crystalline Dystrophy.
|
Asia Pac J Ophthalmol (Phila)
|
2016
|
0.75
|
|
79
|
Physicians' perceptions towards the impact of and willingness to pay for clinical computerization in Hong Kong.
|
Int J Med Inform
|
2004
|
0.75
|
|
80
|
Combined high-dose sub-tenon triamcinolone, intravitreal bevacizumab, and laser photocoagulation for refractory diabetic macular edema: a pilot study.
|
Retina
|
2012
|
0.75
|
|
81
|
Spectral Domain Optical Coherence Tomography Features and Classification Systems for Diabetic Macular Edema: A Review.
|
Asia Pac J Ophthalmol (Phila)
|
2016
|
0.75
|
|
82
|
Ranibizumab in Myopic Choroidal Neovascularization: A Subgroup Analysis by Ethnicity, Age, and Ocular Characteristics in RADIANCE.
|
Ophthalmologica
|
2016
|
0.75
|
|
83
|
TIMP-1 production in human retinal pigment epithelial cells after laser exposure.
|
Yan Ke Xue Bao
|
2005
|
0.75
|
|
84
|
Argon laser photocoagulation for the treatment of idiopathic, bilateral, recurrent, diffuse retinal arterial aneurysms.
|
Ophthalmic Surg Lasers Imaging
|
2003
|
0.75
|